Inhibiting inflammation in rheumatoid arthritis.
Firestein
Gary S
GS
Division of Rheumatology, Allergy, and Immunology and the University of California at San Diego Clinical Investigation Institute, University of California at San Diego School of Medicine, La Jolla, USA.
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000139:chemically induced / Q000188:drug therapy*; D003094:Collagen; D004195:Disease Models, Animal; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D051379:Mice; D018345:Mice, Knockout; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics; D000081082:Phosphoinositide-3 Kinase Inhibitors; D015398:Signal Transduction
D003094:Collagen; D004791:Enzyme Inhibitors; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors